Form 8.3 - HORIZON THERAPEUTICS PLC

Barclays PLC
15 June 2023
 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

1.

KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

HORIZON THERAPEUTICS PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

$0.001 ordinary shares

Date of dealing

14 Jun 2023

2.

INTERESTS AND SHORT POSITIONS

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

$0.001 ordinary shares


Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities 

1,012,362

0.44%

698,966

0.31%

(2)

Derivatives (other than options):

140,756

0.06%

98,064

0.04%

(3)

Options and agreements to purchase/sell:

1,404,500

0.61%

961,400

0.42%

TOTAL:

2,557,618

1.12%

1,758,430

0.77%

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

(3)

Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

 

 

 

 

3.

DEALINGS (Note 4)

(a)

Purchase and sales

 






Class of relevant Security

Purchase/sale

Number of securities

Price per unit

$0.001 ordinary shares

Purchase

12

                 100.0600 USD

$0.001 ordinary shares

Purchase

79

                 100.1867 USD

$0.001 ordinary shares

Purchase

93

                 100.0441 USD

$0.001 ordinary shares

Purchase

100

                 100.2505 USD

$0.001 ordinary shares

Purchase

100

                 100.2750 USD

$0.001 ordinary shares

Purchase

124

                  99.9300 USD

$0.001 ordinary shares

Purchase

200

                 100.2200 USD

$0.001 ordinary shares

Purchase

250

                 100.0244 USD

$0.001 ordinary shares

Purchase

313

                 100.1811 USD

$0.001 ordinary shares

Purchase

314

                 100.1230 USD

$0.001 ordinary shares

Purchase

333

                 100.1355 USD

$0.001 ordinary shares

Purchase

367

                 100.1213 USD

$0.001 ordinary shares

Purchase

507

                 100.2353 USD

$0.001 ordinary shares

Purchase

1,123

                 100.1494 USD

$0.001 ordinary shares

Purchase

2,645

                 100.2331 USD

$0.001 ordinary shares

Purchase

3,040

                 100.2420 USD

$0.001 ordinary shares

Purchase

4,698

                 100.6014 USD

$0.001 ordinary shares

Purchase

7,625

                 100.2373 USD

$0.001 ordinary shares

Purchase

7,982

                 100.4003 USD

$0.001 ordinary shares

Purchase

8,828

                 100.2176 USD

$0.001 ordinary shares

Purchase

9,865

                 100.0264 USD

$0.001 ordinary shares

Purchase

11,739

                 100.6200 USD

$0.001 ordinary shares

Purchase

21,159

                 100.5511 USD

$0.001 ordinary shares

Purchase

33,347

                 100.4098 USD

$0.001 ordinary shares

Sale

1

                 100.3200 USD

$0.001 ordinary shares

Sale

1

                 100.1700 USD

$0.001 ordinary shares

Sale

2

                 100.1150 USD

$0.001 ordinary shares

Sale

12

                 100.1891 USD

$0.001 ordinary shares

Sale

12

                 100.1462 USD

$0.001 ordinary shares

Sale

12

                 100.2116 USD

$0.001 ordinary shares

Sale

24

                  99.9300 USD

$0.001 ordinary shares

Sale

60

                 100.2960 USD

$0.001 ordinary shares

Sale

72

                 100.2745 USD

$0.001 ordinary shares

Sale

76

                 100.4285 USD

$0.001 ordinary shares

Sale

79

                 100.2235 USD

$0.001 ordinary shares

Sale

79

                 100.1867 USD

$0.001 ordinary shares

Sale

100

                  99.9500 USD

$0.001 ordinary shares

Sale

100

                 100.2000 USD

$0.001 ordinary shares

Sale

100

                 100.0200 USD

$0.001 ordinary shares

Sale

100

                 100.3700 USD

$0.001 ordinary shares

Sale

100

                  99.9100 USD

$0.001 ordinary shares

Sale

115

                 100.2064 USD

$0.001 ordinary shares

Sale

129

                 100.4900 USD

$0.001 ordinary shares

Sale

150

                 100.2466 USD

$0.001 ordinary shares

Sale

150

                 100.1166 USD

$0.001 ordinary shares

Sale

183

                 100.0000 USD

$0.001 ordinary shares

Sale

200

                 100.2400 USD

$0.001 ordinary shares

Sale

200

                 100.0650 USD

$0.001 ordinary shares

Sale

397

                 100.1010 USD

$0.001 ordinary shares

Sale

517

                 100.0241 USD

$0.001 ordinary shares

Sale

598

                  99.9858 USD

$0.001 ordinary shares

Sale

900

                  99.9905 USD

$0.001 ordinary shares

Sale

900

                 100.5244 USD

$0.001 ordinary shares

Sale

997

                 100.3233 USD

$0.001 ordinary shares

Sale

1,000

                 100.0135 USD

$0.001 ordinary shares

Sale

1,226

                 100.4003 USD

$0.001 ordinary shares

Sale

1,509

                  99.9944 USD

$0.001 ordinary shares

Sale

1,525

                 100.1019 USD

$0.001 ordinary shares

Sale

1,702

                  99.9527 USD

$0.001 ordinary shares

Sale

2,000

                  99.9992 USD

$0.001 ordinary shares

Sale

2,244

                 100.0771 USD

$0.001 ordinary shares

Sale

3,245

                 100.2558 USD

$0.001 ordinary shares

Sale

3,480

                 100.2838 USD

$0.001 ordinary shares

Sale

4,557

                 100.2553 USD

$0.001 ordinary shares

Sale

5,944

                 100.4256 USD

$0.001 ordinary shares

Sale

6,175

                 100.6200 USD

$0.001 ordinary shares

Sale

23,978

                 100.4961 USD

$0.001 ordinary shares

Sale

39,893

                 100.3808 USD

 
















(b)

Derivatives transactions (other than option transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per unit

 

 

 

 

 
















(c)

Options transactions in respect of existing securities

(i)

Writing, selling, purchasing or varying

Class

 of

 relevant

 security

Product

 description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

Option

 money

 paid/

 received

 per unit

 

 

 

 

 

 

 

 

 
















(ii)

Exercising

 






Product name

Number of

 securities

Exercise price

 per unit

 

 

 

 
















(d)

Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

Details

Price per unit

 (if applicable)

 

 

 

4.

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

 and any other person relating to the voting rights of any relevant securities under any option

 referred to on this form or relating to the voting rights or future acquisition or disposal of any

 relevant securities to which any derivative referred to on this form is referenced. If none, this

 should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

15 Jun 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 








SUPPLEMENTAL FORM 8

 








IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as

appropriate)

OPEN POSITIONS

 







Class of relevant

 security

Product

 Description

Writing,

 purchasing,

 selling,

 varying etc

Number

 of

 securities

 to which

 option

 relates

Exercise

 price

 per unit

Type

Expiry

 date

$0.001 ordinary shares

Put Options

Written

495,500

100

American

16 Jun 2023

$0.001 ordinary shares

Call Options

Written

-25,000

115

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

28,800

095

American

21 Jul 2023

$0.001 ordinary shares

Call Options

Written

-10,600

105

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

2,000

085

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Purchased

-250,000

080

American

16 Jun 2023

$0.001 ordinary shares

Put Options

Written

10,200

080

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

232,000

105

American

16 Jun 2023

$0.001 ordinary shares

Call Options

Written

-2,600

100

American

18 Aug 2023

$0.001 ordinary shares

Call Options

Written

-2,000

100

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Written

400,000

100

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

74,000

090

American

15 Sep 2023

$0.001 ordinary shares

Put Options

Purchased

-544,200

080

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

162,000

105

American

21 Jul 2023

$0.001 ordinary shares

Call Options

Written

-10,000

105

American

16 Jun 2023

$0.001 ordinary shares

Put Options

Purchased

-10,200

100

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Purchased

-106,800

090

American

21 Jul 2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings